Enhancer ID: | E_02_0292 |
Species: | human |
Position : | chr6:151654399-151656399 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | Nothing |
Pubmed ID: | 29851521 |
Enhancer experiment: | HPLC,DSC,FTIR |
Enhancer experiment description: | This study successfully used TP to develop a DA patch with good anti-inflammatory and analgesic effects, proving that TP promotes the release of DA by reducing the interaction between DA and PSA and increasing the mobility of PSA. |
Target gene : | ESR1(ER,ESR,ESRA,ESTRR,Era,NR3A1) |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | This study successfully used TP to develop a DA patch with good anti-inflammatory and analgesic effects, proving that TP promotes the release of DA by reducing the interaction between DA and PSA and increasing the mobility of PSA. |
TF name : | -- |
TF experiment: | HPLC,DSC,FTIR |
TF experiment description: | This study successfully used TP to develop a DA patch with good anti-inflammatory and analgesic effects, proving that TP promotes the release of DA by reducing the interaction between DA and PSA and increasing the mobility of PSA. |
Enhancer function : | This study successfully used TP to develop a DA patch with good anti-inflammatory and analgesic effects, proving that TP promotes the release of DA by reducing the interaction between DA and PSA and increasing the mobility of PSA. |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
This study successfully used TP to develop a DA patch with good anti-inflammatory and analgesic effects, proving that TP promotes the release of DA by reducing the interaction between DA and PSA and increasing the mobility of PSA. |
SNP ID: | -- |
GeneName | Pathway Name | Source | Gene Number |
---|